Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  DENTSPLY International Inc.    XRAY   US2490301072

Delayed Quote. Delayed Nasdaq - 05/29 02:12:06 pm
51.82 USD   -0.63%
05/26 DENTSPLY : to Present at the Stifel 2015 Dental & Veterinary Confere..
05/26 DENTSPLY : International Announces Lab Restructuring
05/20 DENTSPLY : Declares Cash Dividend
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales2 9282 9512 9232 7732 8672 983
Operating income (EBITDA)553570594615646698
Operating profit (EBIT)474489513508505581
Pre-Tax Profit (EBT)331369----
Net income314313323333370405
EPS ( $)2,182,162,242,292,402,87
Dividend per Share ( $)0,220,250,270,340,360,43
Yield0,42%0,48%0,51%0,66%0,69%0,82%
Announcement Date02/20/2013
12:01pm
02/18/2014
12:00pm
02/18/2015
12:01pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt1 4411 4011 001986762541
Finance------
Operating income (EBITDA)553570594615646698
Leverage
(Debt/EBITDA)
2,60x2,46x1,69x1,60x1,18x0,78x
Capital Expenditure92,110099,6104109122
Book Value Per Share (BVPS)15,5 $17,8 $16,5 $16,7 $18,5 $20,7 $
Cash Flow per Share2,57 $2,55 $3,89 $3,42 $3,65 $4,01 $
Announcement Date02/20/2013
12:01pm
02/18/2014
12:00pm
02/18/2015
12:01pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 7 291 M$ -
Entreprise Value (EV) 8 278 M$ 8 053 M$
Valuation 2015e 2016e
PER (Price / EPS) 22,8x 21,7x
Capitalization / Revenue 2,63x 2,54x
EV / Revenue 2,99x 2,81x
EV / EBITDA 13,5x 12,5x
Yield (DPS / Price) 0,66% 0,69%
Price to book (Price / BVPS) 3,12x 2,83x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 18,3% 17,6%
operating Leverage (Delta EBIT / Delta Sales) -0,20x -
Net Margin (Net Profit / Revenue) 12,0% 12,9%
ROA (Net Profit / Asset) 3,91% 4,04%
ROE (Net Profit / Equities) 15,4% 14,9%
Rate of Dividend 14,9% 15,0%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   3,76% 3,79%
Cash Flow / Sales (Taux d'autofinancement) 17,2% 17,8%
Capital Intensity (Assets / Sales) 3,07x 3,19x
Financial Leverage (Net Debt / EBITDA) 1,60x 1,18x
Price Earning Ratio
EPS & Dividend